Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals's GHG Emissions Data Preview
In 2025, Alembic Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Alembic Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy/Paste is a PRO feature.  a | 0000000 | Copy/Paste is a PRO feature. | 0000000 |
Total Scope 3 | Copy/Paste is a PRO feature. | Copy/Paste is a PRO feature. | 0000000 | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0000000 | Copy/Paste is a PRO feature.  a | Copy/Paste is a PRO feature. | 0000000 |
Verified Sources Behind Alembic Pharmaceuticals’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Alembic Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Insights into Alembic Pharmaceuticals's Operational Emissions
In 2025, the total operational greenhouse gas (GHG) emissions of Alembic Pharmaceuticals amounted to 158,244.01 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Alembic Pharmaceuticals increased by 14.11%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
Alembic Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Alembic Pharmaceuticals's Scope 1 emissions?
In 2025, the total Scope 1 emissions of Alembic Pharmaceuticals were 80,278.03 metric tons of CO₂ equivalent (tCO₂e).a
Compared to the previous year (2024), Alembic Pharmaceuticals's Scope 1 emissions increased by 12.86%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
What are Alembic Pharmaceuticals's Scope 2 emissions?
In 2025, Alembic Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 77,965.98 tCO₂e without specifying the calculation method.a
Has Alembic Pharmaceuticals reduced its Scope 2 emissions over time?
Compared to the previous year (2024), Alembic Pharmaceuticals's Scope 2 emissions (Unspecified Calculation Method) rose by 15.43% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
What methodology does Alembic Pharmaceuticals use for Scope 2 reporting?
In 2025, Alembic Pharmaceuticals reported its Scope 2 emissions using an unspecified methodology.a
Alembic Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Alembic Pharmaceuticals’s GHG Emissions Intensity Compared to Industry Peers
In 2025, Alembic Pharmaceuticals reported Scope 1 greenhouse gas (GHG) emissions of 80,278.03 tCO₂e and total revenues of USD 765 millions. This translates into an emissions intensity of 104.88 tCO₂e per millions USD.a
Alembic Pharmaceuticals's Scope 1 Emissions Intensity Compared to Peers
How does Alembic Pharmaceuticals's GHG emissions intensity compare to its peers?
In 2025, Alembic Pharmaceuticals reported a Scope 1 emissions intensity of 104.88 tCO₂e per millions USD. Compared to the peer group median of 22.24, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
Where does Alembic Pharmaceuticals rank on GHG emissions intensity within its industry?
In 2025, Alembic Pharmaceuticals ranked 20 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Alembic Pharmaceuticals among the least efficient performers, with one of the highest emissions intensities in its sector.a